Advertisement

ADVERTISEMENT

Jessica Garlewicz, Digital Managing Editor

Clinical Insights
Beyond the Patient: Quality of Life Impact on Family
09/11/2023
Jessica Garlewicz, Digital Managing Editor
Atopic dermatitis and psoriasis can negatively affect the whole household.
Atopic dermatitis and psoriasis can negatively affect the whole household.
Atopic dermatitis and psoriasis...
09/11/2023
The Dermatologist
NEA Approved Features
Safety of Topical Medications in Pediatric Atopic Dermatitis
09/11/2023
Jessica Garlewicz, Digital Managing Editor
Dr Peter Lio provides a brief on the current topicals used to treat atopic dermatitis in children.
Dr Peter Lio provides a brief on the current topicals used to treat atopic dermatitis in children.
Dr Peter Lio provides a brief on...
09/11/2023
The Dermatologist
psoriasis
Quiz
Trivia: The Superior Efficacy and Safety of Risankizumab
09/11/2023
Jessica Garlewicz, Digital Managing Editor
A recent study showed the superior efficacy and safety of risankizumab when treating moderate psoriasis compared to which other systemic therapy?
A recent study showed the superior efficacy and safety of risankizumab when treating moderate psoriasis compared to which other systemic therapy?
A recent study showed the...
09/11/2023
The Dermatologist
alopecia areata
News
Correlations Between Vitamin D and C-Reactive Protein Levels in Alopecia Areata
09/08/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the connection between vitamin D and c-reactive protein levels in individuals with alopecia areata.
Researchers aimed to investigate the connection between vitamin D and c-reactive protein levels in individuals with alopecia areata.
Researchers aimed to investigate...
09/08/2023
The Dermatologist
Dr Peter Lio
Quiz
Trivia: Dupilumab Systemic Adverse Events
09/07/2023
Jessica Garlewicz, Digital Managing Editor
Dupilumab, the first biologic to be approved down to age 6 months, has what specific systemic adverse events?
Dupilumab, the first biologic to be approved down to age 6 months, has what specific systemic adverse events?
Dupilumab, the first biologic to...
09/07/2023
The Dermatologist
psoriatic arthritis
News
DNA Methylation Patterns in CD4+ T Cells Discriminate Between Psoriasis and Psoriatic Arthritis
09/06/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to uncover disease-associated DNA methylation patterns in CD4+ T cells from patients with psoriasis and psoriatic arthritis.
Researchers aimed to uncover disease-associated DNA methylation patterns in CD4+ T cells from patients with psoriasis and psoriatic arthritis.
Researchers aimed to uncover...
09/06/2023
The Dermatologist
psoriasis
News
Psoriasis Vulgaris Complicated by Metabolic Syndrome Due to Higher IL-9 Levels
08/31/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate this connection by examining the levels of IL-9 and its receptor in patients with psoriasis vulgaris and metabolic syndrome.
Researchers aimed to investigate this connection by examining the levels of IL-9 and its receptor in patients with psoriasis vulgaris and metabolic syndrome.
Researchers aimed to investigate...
08/31/2023
The Dermatologist
alopecia areata
News
A Retrospective Claims Analysis of Treatment Patterns Among Patients With Alopecia Areata
08/31/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the treatment patterns of individuals in the USA with alopecia areata.
Researchers aimed to investigate the treatment patterns of individuals in the USA with alopecia areata.
Researchers aimed to investigate...
08/31/2023
The Dermatologist
Abigail Cline, MD, PhD, FAAD
Q&As
Insights on the Application of Dupilumab for Pediatric Patients Aged 6 to 11 Years With Moderate to Severe Atopic Dermatitis
08/24/2023
Jessica Garlewicz, Digital Managing Editor
Following her recent study, Dr Abigail Cline discusses what further research is needed to evaluate dupilumab’s effectiveness and the occurrence of adverse effects.
Following her recent study, Dr Abigail Cline discusses what further research is needed to evaluate dupilumab’s effectiveness and the occurrence of adverse effects.
Following her recent study, Dr...
08/24/2023
The Dermatologist
Alopecia Areata
News
Immune-Mediated Alopecia Areata Associated With COVID-19 Vaccinations
08/23/2023
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the relationship between COVID-19 vaccines and alopecia areata (AA) in a study that included 27 patients who developed AA after receiving COVID-19 vaccines.
Researchers aimed to investigate the relationship between COVID-19 vaccines and alopecia areata (AA) in a study that included 27 patients who developed AA after receiving COVID-19 vaccines.
Researchers aimed to investigate...
08/23/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use